Board of Rephaiah
Hellen is a Pan-African social justice leader, an ambitious networked and entrepreneurial governance, communications, and partnerships-building expert from Malawi with 14 years of professional experience in various countries working with international organizations, Non-Governmental Organizations, Governments, and privately owned firms. Hellen is a board member at Rephaiah.
Joshua is a Private Sector and Business Development Specialist. He was the Director of Investment Promotion and Facilitation with the Malawi Investment and Trade Center (MITC), responsible for attracting, promoting, and facilitating investment into Malawi. He presently works with the Malawi Millennium Development Trust, which, together with the Millenium Challenge Corporation of the USA, is building an economically enhancing, poverty-reducing project for Malawi called COMPACT II. Joshua is a board member at Rephiah.
Sveinbjorn is a professor in clinical pharmacokinetics and toxicology at the University of Iceland. He is also an Honorary lecturer at Kamuzu University of Health Sciences in Malawi. Sveinbjorn has one drug on the marekt, Nayzilam, that took 20 years to develop and 12 years through phases I-III. He has worked as a consultant for multiple companies around the world, mainly on intranasal drug and vaccine development.
The Rephaiah Team
Precious Ngwalero Katundu
Precious is a pharmacist and a lecturer at the Kamuzu University of Health Sciences in Malawi. Before joining Kamuzu University of Health Sciences, she worked as a Pharmacist in Charge at Zomba Central hospital - one of the referral hospitals in Malawi. She is finalizing her Ph.D. in Clinical pharmacology at the University of Cape Worn, South Africa. Precious will be the Chief Executive for Rephaiah.
Baxter H Kachingwe
Baxter is a Lecturer in Pharmaceutics and Biopharmaceutics at the Pharmacy Department of the Kamuzu University of Health Sciences (KUHeS). He is a Pharmacist and holds a Ph.D. in Pharmaceutical Sciences from Taipei Medical University and is involved in standards development as a chairperson of the Technical Committee of the African Standardization in the harmonization of African standards for pharmaceutical and medicinal products. Baxter believes in investing and empowering Malawian pharmacists so they can able to develop the pharmaceutical industry is a former head of the Pharmacy Department of Pharmacy at KUHeS. He will be the Chief Scientific offer and Chief Operations Officer for Rephaiah.
Emmanuel work for Ministry of Mining in Malawi, auditing operations across the country. He is an expert in environmental chemistry, inspection and monitoring as well as occupational health.
Ellen K. G. Mhango
Ellen is a lecturer in Pharmaceutics at the Pharmacy department of Kamuzu University of Health Sciences. She is a pharmacist and is currently working on her Ph.D. project at the University of Iceland, Faculty of Pharmaceutical Sciences, where she focuses on pediatric antimalarial formulations.
Heather Musasa Mbiri
Heather is a green architect focusing on utilizing and incorporating the environment into the construction to achieve optimal benefits from wind, rain, and sun.
Peter is a drug development specialist at BioProducts Laboratory, Cobra Biologics, and GlaxoSmithKline. He also served as Malawi's Minister of Health. Currently, he is a senior lecturer at Kamuzu University of Health Sciences, where his research interest is developing new drugs for diseases that particularly affect the developing world.
With a background in Communication and Political Sciences, he has been advising the Rephaiah project since 2019/2020. Joseph is currently serving as the First Secretary for Malawi Mission to the UN in Geneva. Embassy to Switzerland and Austria.
Dr. Lazarus Joziwelo
Lazarus is responsible for the eradication of bilharzia (schistosomiasis), in Malawi. He serves at the Ministry of Health of Malawi, Department of Neglected Tropical Diseases.
Dr. Lester Chitsulu
Lester served at the Department of Neglected Tropical Diseases for 16 years at World Health Organization, focusing on bilharzia (schistosomiasis). He initiated the Pediatric Praziquantel Consortium several years ago. He has now retired and has consulted and supported the Rephiah project.
Mr. Paul Uzureau
Paul is a retired engineer and architect, an expert in pharmaceutical and biotechnological industry. He has designed all the conceptual drawings for Rephaiah in Malawi.
Dr. Wane Gruden
Professor Gruden an author of the book "The Poverty of Nations: A Sustainable Solutions" together with Barry Asmus. This book focuses on how to establish sustainable and effective solutions in low-income countries. He has provided valuable advise and support over the years.